Urinary prostaglandin D2 metabolite appears to be a useful biomarker for evaluating the status of egg oral immunotherapy in children

J Allergy Clin Immunol Pract. 2021 Nov;9(11):4164-4166.e2. doi: 10.1016/j.jaip.2021.06.040. Epub 2021 Jul 15.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Biomarkers
  • Child
  • Egg Hypersensitivity* / diagnosis
  • Egg Hypersensitivity* / therapy
  • Humans
  • Immunotherapy
  • Prostaglandin D2
  • Prostaglandins*

Substances

  • Biomarkers
  • Prostaglandins
  • Prostaglandin D2